Varex Imaging Corporation
HealthcareNASDAQ:VREX · NASDAQ Global Select
+$0.01 today
Vol 0.34M · Avg 0.36M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-14.9%
avg 3.1%
ROIC
-3.0%
avg 2.3%
ROA
-6.3%
avg 2.4%
Analysis
ROIC is currently the strongest return metric at -3.0% versus its period average of 2.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Sunny S. Sanyal | President, Chief Executive Officer & Director | $1.97M | — | 62 | $4,178.00 | <0.01% |
Shubham Maheshwari | Chief Financial Officer & Principal Accounting Officer | $1.08M | — | 55 | $7,354.00 | 0.02% |
Andrew J. Hartmann | Senior Vice President & GM of X-ray Detectors | $812,150.00 | — | 63 | $4,178.00 | <0.01% |
Kimberley E. Honeysett | Advisor | $786,361.00 | — | 56 | $4,002.00 | <0.01% |
Mark S. Jonaitis | Senior Vice President & GM of X-Ray Sources | $740,235.00 | — | 64 | $4,178.00 | <0.01% |
Karen Aranki | Chief Human Resources Officer | $450,175.00 | — | 51 | $3,510.00 | <0.01% |
Victor Garcia | Senior Vice President of Regulatory & Quality Compliance | — | — | — | $0.00 | <0.01% |
Wouter Vlaanderen | Vice President of Global Marketing and GM of Connect & Control | — | — | — | — | — |
Christopher John Belfiore | Director of Investor Relations | — | — | — | $0.00 | <0.01% |
Matthew Martinez | Chief Legal Officer & Corporate Secretary | — | — | 44 | $17,094.00 | 0.04% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
4
$140,886.31
Net Sentiment
$140,886.31
Net selling
Most Active
Kunkel Jay K.
3 transactions
Analysis
Insiders reported 0 buys worth $0.00 and 4 sells worth $140,886.31 over the last 12 months. That adds up to net selling of $140,886.31. Kunkel Jay K. was the most active insider with 3 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -22.0% | +3.0% (13yr)1 analysts |
| Revenue | N/A | N/A | +0.6% | +3.4% (13yr)1 analysts |
| Net Income | N/A | N/A | -22.3% | +3.7% (13yr)1 analysts |
| EBIT | N/A | N/A | -21.9% | -3.2% (13yr)1 analysts |
Analysis
Recent growth has been strongest in Revenue at +0.6% over three years. Forward estimates point to Net Income at +3.7% (13yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Avanos Medical, Inc.
NYSE:AVNS
$1.17B
Lexicon Pharmaceuticals, Inc.
NASDAQ:LXRX
$852.86M
Cullinan Therapeutics, Inc.
NASDAQ:CGEM
$841.97M
CeriBell, Inc.
NASDAQ:CBLL
$700.80M
Omeros Corporation
NASDAQ:OMER
$632.20M
Cytek Biosciences, Inc.
NASDAQ:CTKB
$511.40M
Orthofix Medical Inc.
NASDAQ:OFIX
$376.33M
Standard BioTools Inc.
NASDAQ:LAB
$346.53M
Bicycle Therapeutics plc
NASDAQ:BCYC
$281.05M
So-Young International Inc.
NASDAQ:SY
$244.05M
Who manages VREX?
Varex Imaging Corporation (VREX) lists 10 active executives. The top listed executive is Andrew J. Hartmann, Senior Vice President & GM of X-ray Detectors.
Are VREX insiders buying or selling?
Recent insider activity shows net selling of $2.82M.
Explore More
Continue the stock analysis
Jump to another research area for this company.